Cyclooxygenase-2 inhibitor reduces simvastatin-induced bone morphogenetic protein-2 and bone formation in vivo

被引:27
|
作者
Bradley, J. D.
Cleverly, D. G.
Burns, A. M.
Helm, N. B.
Schmid, M. J.
Marx, D. B.
Cullen, D. M.
Reinhardt, R. A.
机构
[1] Univ Nebraska, Med Ctr, Coll Dent, Dept Surg Special, Lincoln, NE 68583 USA
[2] Univ Nebraska, Med Ctr, Coll Dent, Dept Oral Biol, Lincoln, NE 68583 USA
[3] Univ Nebraska, Dept Biometry, Lincoln, NE 68583 USA
[4] Creighton Univ, Osteoporosis Res Ctr, Omaha, NE 68178 USA
关键词
bone formation rate; bone morphogenetic protein-2; cyclooxygenase-2; simvastatin;
D O I
10.1111/j.1600-0765.2006.00943.x
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
Simvastatin, a cholesterol-lowering drug, also stimulates oral bone growth when applied topically, without systemic side-effects. However, the mechanisms involved in vivo are not known. We hypothesized that bone morphogenetic protein-2, nitric oxide synthase, and cyclooxygenase-2 are involved, based on prior in vitro evidence. A rat bilateral mandible model, where 0.5 mg of simvastatin in methylcellulose gel was placed on one side and gel alone on the other, was used to quantify nitric oxide, cyclooxygenase-2 and bone morphogenetic protein-2 (via tissue extraction, enzyme activity or immunoassay), and to analyze the bone formation rate (via undecalcified histomorphometry). Cyclooxygenase-2 and nitric oxide synthase inhibitors (NS-398 and L-NAME, respectively) were administered intraperitoneally. Simvastatin was found to stimulate local bone morphogenetic protein-2, nitric oxide and the regional bone formation rate (p < 0.05), whereas NS-398 inhibited bone morphogenetic protein-2 and reduced the bone formation rate (p < 0.05). These data suggest an association between simvastatin-induced bone morphogenetic protein-2 and bone formation in the mandibular microenvironment, and the negative effect of cyclooxygenase-2 inhibitors on bone growth.
引用
收藏
页码:267 / 273
页数:7
相关论文
共 50 条
  • [21] Antiangiogenic agent (TNP-470) inhibition of ectopic bone formation induced by bone morphogenetic protein-2
    Mori, S
    Yoshikawa, H
    Hashimoto, J
    Ueda, T
    Funai, H
    Kato, M
    Takaoka, K
    BONE, 1998, 22 (02) : 99 - 105
  • [22] Effect of hyperbaric oxygenation on bone induced by recombinant human bone morphogenetic protein-2
    Okubo, Y
    Bessho, K
    Fujimura, K
    Kusumoto, K
    Ogawa, Y
    Iizuka, T
    BRITISH JOURNAL OF ORAL & MAXILLOFACIAL SURGERY, 2001, 39 (02): : 91 - 95
  • [23] Experimental tooth movement into bone induced by recombinant human bone morphogenetic protein-2
    Kawamoto, T
    Motohashi, N
    Kitamura, A
    Baba, Y
    Suzuki, S
    Kuroda, T
    CLEFT PALATE-CRANIOFACIAL JOURNAL, 2003, 40 (05): : 538 - 543
  • [24] Effect of Biomaterial Electrical Charge on Bone Morphogenetic Protein-2-Induced In Vivo Bone Formation
    Olthof, Maurits G. L.
    Kempen, Diederik H. R.
    Liu, Xifeng
    Dadsetan, Mahrokh
    Tryfonidou, Marianna A.
    Yaszemski, Michael J.
    Dhert, Wouter J. A.
    Lu, Lichun
    TISSUE ENGINEERING PART A, 2019, 25 (13-14) : 1037 - 1052
  • [25] Expression of bone morphogenetic protein in the course of osteoinduction by recombinant human bone morphogenetic protein-2
    Okubo, Y
    Bessho, K
    Fujimura, K
    Kusumoto, K
    Ogawa, Y
    Iizuka, T
    CLINICAL ORAL IMPLANTS RESEARCH, 2002, 13 (01) : 80 - 85
  • [26] Selective cyclooxygenase-2 inhibitor reduces accelerated bone resorption in collagen-induced arthritis mice
    Taketa, T
    Sakai, A
    Okimoto, N
    Onishi, H
    Nakamura, T
    ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 : 158 - 158
  • [27] Bone morphogenetic protein-2 is induced in the heart after ischemic injury
    Rutkovskiy, A.
    Czibik, G.
    Oloviannikova, M.
    Reine, T. M.
    Sagave, J.
    Valen, G.
    Vaage, J.
    CARDIOVASCULAR RESEARCH, 2014, 103
  • [28] Improvement in the delivery system of bone morphogenetic protein-2: a new approach to promote bone formation
    Zhang, Quan
    He, Qi-Fen
    Zhang, Tong-Han
    Yu, Xiao-Lin
    Liu, Qin
    Deng, Fei-long
    BIOMEDICAL MATERIALS, 2012, 7 (04)
  • [29] Effect of Targeted Delivery of Bone Morphogenetic Protein-2 on Bone Formation in Type 1 Diabetes
    de Santana, Ronaldo Barcellos
    Trackman, Phillip C.
    INTERNATIONAL JOURNAL OF ORAL & MAXILLOFACIAL IMPLANTS, 2015, 30 (03) : 707 - 714
  • [30] The in vivo and in vitro effects of bone morphogenetic protein-2 on the development of the chick mandible
    Ekanayake, S
    Hall, BK
    INTERNATIONAL JOURNAL OF DEVELOPMENTAL BIOLOGY, 1997, 41 (01): : 67 - 81